Overview

Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)

Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Cetuximab in metastatic penile carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Centre Leon Berard
Treatments:
Cetuximab
Ifosfamide
Paclitaxel